Beam Therapeutics Inc.
BEAM
36 insider filings · Latest: Oct 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Sale | 25,000 | $22.76 | $569.1K | 986,667(D) | View → |
| Mar 30, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Sale | 25,000 | $22.37 | $559.2K | 986,667(D) | View → |
| Apr 2, 2026 | Mar 31 8:33 PM | CHRISTINE BELLON | Proposed Sale | 20,000 | $21.90 | $438.0K | — | View → |
| Apr 2, 2026 | Mar 31 8:29 PM | GIUSEPPE CIARAMELLA | Proposed Sale | 26,250 | $21.90 | $574.9K | — | View → |
| Apr 2, 2026 | Mar 31 8:22 PM | AMY SIMON | Proposed Sale | 20,000 | $21.90 | $438.0K | — | View → |
| Apr 2, 2026 | Mar 31 8:19 PM | JOHN M. EVANS | Proposed Sale | 66,874 | $21.90 | $1.5M | — | View → |
| Mar 31, 2026 | Mar 31 8:16 PM | JOHN M EVANS | Proposed Sale | 25,000 | $22.76 | $569.1K | — | View → |
| Mar 30, 2026 | Mar 30 9:28 PM | JOHN M EVANS | Proposed Sale | 25,000 | $22.37 | $559.2K | — | View → |
| Feb 24, 2026 | Feb 26 9:05 PM | Giuseppe CiaramellaPresident | Sale | 35,000 | $32.00 | $1.1M | 190,216(D) | View → |
| Feb 24, 2026 | Feb 24 9:15 PM | GIUSEPPE CIARAMELLA | Proposed Sale | 35,000 | $32.00 | $1.1M | — | View → |
| Jan 30, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Sale | 25,000 | $28.36 | $708.9K | 986,667(D) | View → |
| Jan 29, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Sale | 25,000 | $29.38 | $734.6K | 986,667(D) | View → |
| Jan 30, 2026 | Jan 30 9:04 PM | JOHN M EVANS | Proposed Sale | 25,000 | $28.36 | $708.9K | — | View → |
| Jan 29, 2026 | Jan 29 9:01 PM | JOHN M EVANS | Proposed Sale | 25,000 | $29.38 | $734.6K | — | View → |
| Jan 22, 2026 | Jan 26 9:05 PM | Bethany J CavanaghSVP, Finance and Treasurer | Sale | 6,198 | $35.00 | $216.9K | 34,813(D) | View → |
| Jan 22, 2026 | Jan 26 9:05 PM | Christine BellonChief Legal Officer | Sale | 1,371 | $34.00 | $46.6K | 95,667(D) | View → |
| Jan 22, 2026 | Jan 22 9:03 PM | CHRISTINE BELLON | Proposed Sale | 1,371 | $34.00 | $46.6K | — | View → |
| Jan 20, 2026 | Jan 21 9:05 PM | Bethany J CavanaghSVP, Finance and Treasurer | Sale | 3,034 | $30.12 | $91.4K | 41,011(D) | View → |
| Jan 15, 2026 | Jan 20 9:05 PM | Christine BellonChief Legal Officer | Sale | 18,629 | $34.61 | $644.8K | 97,038(D) | View → |
| Jan 15, 2026 | Jan 15 11:00 PM | CHRISTINE BELLON | Proposed Sale | 18,629 | $34.61 | $644.8K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 93,672(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Amy SimonChief Medical Officer | Grant/Award | 88,500 | $27.62 | 88,500(D) | View → |
← Previous
Page 2 of 2